IDEAYA Biosciences to Participate in the 2023 Guggenheim Oncology Conference
Yahoo! Finance
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the 2023 Guggenheim Oncology Conference.
Continue Reading